Latest news for  (OTC:RCINS) Stock

Mizuho analyst Gregg Moskowitz maintains Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) with a Outperform and lowers the price target from $225 to $220.

News

Price Target

Analyst Ratings

TEAM

Mizuho Maintains Outperform on Atlassian, Lowers Price Target to $220

Needham analyst Scott Berg reiterates SEMrush Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEMR#NYSE">SEMR</a>) with a Buy and maintains $18 price target.

Reiteration

SEMR

Needham Reiterates Buy on SEMrush Hldgs, Maintains $18 Price Target

<ul>
<li>300 patients enrolled in the study, including patients with and without the cognitive biomarker &ndash;</li>
<li>On track to report topline data in October 2024 &ndash;</li>
<li>Alto to host investor day focused on ALTO-100 on September 9, 2024 &ndash;</li>
</ul>

ANRO

Alto Neuroscience Completes Enrollment In ALTO-100 Phase 2b Study, Topline Results Expected In October

General

Redwire Secures Follow-On Order For Roll-Out Solar Arrays For Thales Alenia Space's Newest Telecommunications Satellite Product Line

WIIM

State Street shares are trading higher following better-than-expected Q2 financial results.

State Street (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) reported quarterly earnings of $2.15 per share which beat the analyst consensus estimate of $2.03 by 5.91 percent. The company reported quarterly sales of $3.191 billion which beat the analyst consensus estimate of $3.146 billion by 1.42 percent. This is a 2.60 percent increase over sales of $3.110 billion the same period last year.

Earnings

Earnings Beats

State Street Q2 2024 GAAP EPS $2.15 Beats $2.03 Estimate, Total Revenue $3.191B Beat $3.146B Estimate

MDWD

MediWound Selected For €16.25M Funding From The European Innovation Council Accelerator Program

Morgan Stanley analyst Mike Cyprys maintains BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) with a Overweight and raises the price target from $1013 to $1036.

Morgan Stanley Maintains Overweight on BlackRock, Raises Price Target to $1036

Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.72 by 1.39 percent. The company reported quarterly sales of $4.69 billion which beat the analyst consensus estimate of $4.68 billion by 0.20 percent. This is a 0.73 percent increase over sales of $4.66 billion the same period last year.

SCHW

Charles Schwab Q2 2024 Adj EPS $0.73 Beats $0.72 Estimate, Sales $4.69B Beat $4.68B Estimate

Morgan Stanley shares are trading higher following better-than-expected Q2 earnings.

Philip Morris International U.S. Affiliate To Create 500 Jobs Investing $600M In Colorado Manufacturing Facility

Biotech

Health Care

BTAI

BioXcel Therapeutics Announced Preliminary Sales Of Igalmi (Dexmedetomidine) Sublingual Film For Q2 Of Approximately $1.1M, Up Approximately 90% Quarter Over Quarter And Approximately 141% Year-over-year

Dividends

Morgan Stanley Raises Dividend From $0.85 To $0.925/Share

Morgan Stanley analyst Betsy Graseck maintains Goldman Sachs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) with a Overweight and raises the price target from $475 to $513.

Morgan Stanley Maintains Overweight on Goldman Sachs Gr, Raises Price Target to $513

Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) reported quarterly earnings of $1.82 per share which beat the analyst consensus estimate of $1.65 by 10.3 percent. The company reported quarterly sales of $15.00 billion which beat the analyst consensus estimate of $14.30 billion by 4.90 percent. This is a 11.47 percent increase over sales of $13.46 billion the same period last year.

Morgan Stanley Q2 2024 Adj EPS $1.82 Beats $1.65 Estimate, Sales $15.00B Beat $14.30B Estimate

The Dow Jones index closed higher by more than 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Bespoke Extracts</h3>
<ul>
<li>The Trade: Bespoke Extracts, Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BSPK#OTC">BSPK</a>) CEO Michael Feinsod <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 3,000 shares at</a> an average price of $0.07. To acquire these shares, it cost around $210.</li>
<li>What's Happening: The company&#8217;s stock jumped around 268% over the past six months.</li>
<li>What Bespoke Extracts Does: Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products.</li>
</ul>
<h3 class="wp-block-heading">Thunder Mountain Gold</h3>
<ul>
<li>The Trade: Thunder Mountain Gold, Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/THMG#OTC">THMG</a>) CEO Eric T Jones acqu<a href="https://www.benzinga.com/sec/insider-trades/">ired a total of 125,000 shares a</a>t an average price of $0.06. To acquire these shares, it cost around $6,875.</li>
<li>What's Happening: The company's stock gained around 38% over the past six months.</li>
<li>What Thunder Mountain Gold Does: Thunder Mountain Gold Inc is a mineral exploration stage company. It is engaged in exploring mining properties that have the potential to produce gold, silver, base metals, and other commodities.</li>
</ul>
<h3 class="wp-block-heading">Tecogen</h3>
<ul>
<li>The Trade: Tecogen Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGEN#OTC">TGEN</a>) Director Earl R Lewis <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 10,000 shares</a> at an average price of $0.68. The insider spent around $6,800 to buy those shares. </li>
<li>What's Happening: On May 8, Tecogen reported revenues of $6.2 million and net loss of $1.1 million for the quarter ended March 31.</li>
<li>What Tecogen Does: Tecogen Inc, designs, manufactures, markets, and maintains high-efficiency, ultra-clean cogeneration products.</li>
</ul>
<h3 class="wp-block-heading">Perfect Moment</h3>
<ul>
<li>The Trade: Perfect Moment Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PMNT#NYSE">PMNT</a>) Chief Creative Officer Jane Gottschalk <a href="https://www.benzinga.com/quote/aei/analyst-ratings">acquired a total of 5,600 shares</a> at an average price of $1.63. The insider spent around $9,129 to buy those shares.</li>
<li>What's Happening: On July 9, ThinkEquity analyst Ashok Kumar initiated coverage on Perfect Moment with a Buy rating and announced a price target of $6.</li>
<li>What Perfect Moment Does: Perfect Moment Ltd is a company which is a luxury lifestyle brand that combines fashion and technical performance for its ranges of skiwear, outerwear, swimwear, and activewear.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39770427/top-5-consumer-stocks-that-may-explode-in-q3">Top 5 Consumer Stocks That May Explode In Q3</a></li>
</ul>

Long Ideas

Penny Stocks

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

BSPK

PMNT

TGEN

THMG

Tecogen And 3 Other Stocks Under $5 Insiders Are Buying

Needham analyst Ami Fadia maintains Revolution Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVMD#NASDAQ">RVMD</a>) with a Buy and raises the price target from $46 to $62.

RVMD

Needham Maintains Buy on Revolution Medicines, Raises Price Target to $62

During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments">high dividend payout</a>. 
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the industrials sector.
<h3 class="wp-block-heading">Paychex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>)</h3>
<ul>
<li>Dividend Yield: 3.22%</li>
<li>Morgan Stanley analyst James Faucette maintained an Equal-Weight rating and cut the price target from $125 to $122 on June 27. This analyst has an accuracy rate of 67%.</li>
<li>Baird analyst Mark Marcon maintained a Neutral rating and slashed the price target from $126 to $124 on June 27. This analyst has an accuracy rate of 69%.</li>
<li>Recent News: On July 10, the company's board declared a regular quarterly cash dividend of 98 cents per share.</li>
<li><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071624&amp;t=be2bearmibe3na1">Benzinga Pro's real-time newsfeed</a> alerted to latest PAYX's news</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="674" height="735" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/16072408/Screenshot-2024-07-16-at-4.54.02-PM.png" alt="" class="wp-image-438128" style="width:421px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/16072408/Screenshot-2024-07-16-at-4.54.02-PM.png 674w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/16072408/Screenshot-2024-07-16-at-4.54.02-PM-275x300.png 275w" sizes="(max-width: 674px) 100vw, 674px" /></a></figure>
<h3 class="wp-block-heading">Kennametal Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMT#NYSE">KMT</a>)</h3>
<ul>
<li>Dividend Yield: 3.27%</li>
<li>Barclays analyst Julian Mitchell maintained an Equal-Weight rating and cut the price target from $25 to $24 on July 10. This analyst has an accuracy rate of 75%.</li>
<li>Loop Capital analyst Chris Dankert maintained a Hold rating and cut the price target from $24 to $22 on June 21. This analyst has an accuracy rate of 74%.</li>
<li>Recent News: On May 8, Kennametal posted weaker-than-expected quarterly earnings.</li>
<li>Benzinga Pro's charting tool helped identify the <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071624&amp;t=be2bearmibe3na1">trend in Kennametal's stock</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="689" height="753" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/16072442/Screenshot-2024-07-16-at-4.54.37-PM.png" alt="" class="wp-image-438132" style="width:457px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/16072442/Screenshot-2024-07-16-at-4.54.37-PM.png 689w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/16072442/Screenshot-2024-07-16-at-4.54.37-PM-275x300.png 275w" sizes="(max-width: 689px) 100vw, 689px" /></a></figure>
<h3 class="wp-block-heading">Stanley Black &amp; Decker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWK#NYSE">SWK</a>)</h3>
<ul>
<li>Dividend Yield: 3.73%</li>
<li>Barclays analyst Julian Mitchell downgraded the stock from Overweight to Equal-Weight and cut the price target from $100 to $86 on June 4. This analyst has an accuracy rate of 75%.</li>
<li>Baird analyst Timothy Wojs maintained a Neutral rating and cut the price target from $82 to $80 on April 19. This analyst has an accuracy rate of 68%.</li>
<li>Recent News: Stanley Black &amp; Decker is expected to broadcast its second quarter earnings webcast on Tuesday, July 30.</li>
<li>Benzinga Pro's signals feature notified of a potential <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071624&amp;t=be2bearmibe3na1">breakout in SWK's shares</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="668" height="701" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/16072517/Screenshot-2024-07-16-at-4.55.13-PM.png" alt="" class="wp-image-438133" style="width:431px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/16072517/Screenshot-2024-07-16-at-4.55.13-PM.png 668w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/16072517/Screenshot-2024-07-16-at-4.55.13-PM-286x300.png 286w" sizes="(max-width: 668px) 100vw, 668px" /></a></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39786459/bank-of-america-morgan-stanley-and-other-3-stocks-to-watch-heading-into-tuesday">Bank Of America, Morgan Stanley And Other 3 Stocks To Watch Heading Into Tuesday</a></li>
</ul>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>

PAYX

Wall Street's Most Accurate Analysts Weigh In On 3 Industrials Stocks Delivering High-Dividend Yields

Keefe, Bruyette &amp; Woods analyst Aidan Hall maintains BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) with a Outperform and raises the price target from $915 to $934.

Keefe, Bruyette & Woods Maintains Outperform on BlackRock, Raises Price Target to $934

Needham analyst David Saxon reiterates Envista Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVST#NYSE">NVST</a>) with a Hold.